Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

NCT00474812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: dasatinib
PROCEDURE: laboratory biomarker analysis
PROCEDURE: physiologic testing

Sponsor

National Cancer Institute (NCI)